SCHEMBL14723749

SCHEMBL14723749

CN(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc(-c2ccc(NC(=O)OC(C)(C)C)cc2)cc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.61
NPC1 O15118 1/20 0.50
CYP2C9 P11712 6/20 0.49
CYP2C19 P33261 6/20 0.49
CYP3A4 P08684 5/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 2/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
JAK2 O60674 1/20 0.44
CMA1 P23946 2/20 0.44
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43
PABPC1 P11940 1/20 0.43
EP300 Q09472 1/20 0.42
CREBBP Q92793 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13379471 0.92 KCNH2 (0.52) KCNH2NPC1CYP2C9CYP2C19CYP3A4
SCHEMBL14723755 0.91 KCNH2 (0.67) KCNH2CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL17488508 0.91 KCNH2 (0.67) KCNH2CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL17474761 0.91 KCNH2 (0.67) KCNH2CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL14723756 0.91 KCNH2 (0.67) KCNH2CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL13388623 0.88 KCNH2 (0.60) KCNH2NPC1CYP2C9CYP2C19CYP3A4
SCHEMBL14723750 0.88 KCNH2 (0.65) KCNH2NPC1CYP2C9CYP2C19CYP3A4
SCHEMBL14723751 0.86 KCNH2 (0.61) KCNH2CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL14723748 0.86 KCNH2 (0.61) KCNH2CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL2195528 0.84 KCNH2 (0.59) KCNH2CYP2C9CYP2C19CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383094-B2 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-26 US disclosed